McKesson Corp. Upgraded to "Conviction-Buy" by Goldman Sachs
Shares of McKesson Corp. traded down 0.46% during mid-day trading on Wednesday, hitting $181.53.
Trending on the Topix Network
Tue Mar 11, 2014
Ohio Attorney General DeWine Announces Settlement in Drug Pricing Lawsuit
Ohio Attorney General Mike DeWine today announced that his office has reached an $18.325 million dollar settlement in a lawsuit brought against McKesson Corporation for an alleged scheme to inflate the price of drugs prescribed for beneficiaries of the Ohio Public Employees Retirement System , State Teachers Retirement System of Ohio , and the Ohio ... (more)
McKesson Announces QICS for Cardiology
As hospital administrators continue to try to get their arms around proving the quality of care improvements required by regulatory bodies while getting paid less to do so, McKesson announces a new cardiology solution that helps hospitals do more with less.
Mon Mar 10, 2014
Fitch Rates McKesson's $4.1 Billion Notes Issuance 'BBB+'
The Rating Outlook is Negative. A full list of ratings follows at the end of this release.
Sun Mar 09, 2014
Customer Interaction Solutions
McKesson Elects Dr. Anthony Coles as New Independent Director [Health & Beauty Close - Up]
As a next step in a series of corporate governance modifications, McKesson Corp. said that its Board of Directors has elected N. Anthony Coles, M.D., as a new independent director, effective April 29. In connection with Dr. Coles' election, the size of the Board of Directors was increased from nine to ten members, nine of whom are independent, the ... (more)
Fri Mar 07, 2014
McKesson Earns KLAS Category Leader Distinction for 2013
McKesson Pharmacy Systems & Automation announced today that EnterpriseRx - its cloud-based, centrally hosted pharmacy management system - earned top honors as a Category Leader in the 2013 Best in KLAS: Software and Services report.
Wed Mar 05, 2014
McKesson Board of Directors Elects N. Anthony Coles as New Independent Director
As a next step in a series of corporate governance modifications, McKesson Corporation today announced that its Board of Directors has elected N. Anthony Coles, M.D., as a new independent director, effective April 29, 2014.
Fitch Rates McKesson's $4.1 Billion Notes Issuance 'BBB+'
A full list of ratings follows at the end of this release. MCK plans to use the proceeds of its ), on a fully diluted basis.
Press release distribution, EDGAR filing, XBRL, regulatory filings
Fitch expects to rate the transaction and assign Rating O... )--Appfire, de meest betrouwbare leverancier van Atlassian Enterpise-producten en -diensten, heeft vandaag een driejarenplan aangekondigd om te investeren in d... )--Research and Markets has announced the addition of the "Strategic Analysis of the European and North American ... )--FUND A ... (more)
Tue Mar 04, 2014
Physicians Interactive and McKesson Announce Partnership to Provide Coupons on Demand
READING, Mass., March 4, 2014 /PRNewswire/ -- Physicians Interactive , the leading provider of online and mobile clinical resources and solutions for healthcare professionals , and McKesson Patient Relationship Solutions , a leading provider of pharmaceutical manufacturer-sponsored patient adherence programs, are collaborating to jointly deliver ... (more)
Fri Feb 28, 2014
Tesla near lows of recent range, levels to watch
Active equity options trading Active equity options trading on open according to Track Data: AAPL TSLA C X GILD LNKD KO MSFT Options Update; February 18, 2014 iPath S&P 500 VIX Short-Term Futures down 49c to 41.46.
Cheap Growth A Key Highlight For Rite Aid
I reiterate my bullish stance on Rite Aid Corp. as the company is likely to benefit from healthcare reforms , reacceleration of generics in the near future, an aging U.S. population and strengthening of the balance sheet.
McKesson Corp Files (8-K) Disclosing Change in Directors or Principal ...
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
McKesson Launches Takeover Offer for Remaining Celesio Shares
The publication of the offer document for the Takeover Offer has been approved by the Bundesanstalt fr Finanzdienstleistungsaufsicht and is now available on www.GlobalHealthcareLeader.com in German and in an English translation.
Wall Street Journal
McKesson Changes Executive Compensation Program
Medical-products distributor McKesson Corp. said it made more changes to its executive compensation programs and its chief executive voluntarily reduced his pension benefit, after activist investors complained about the company's pay structure.
McKesson Announces Further Changes to Corporate Governance and Compensation Practices
These changes build on the modifications announced on January 21, 2014. John H. Hammergren, the Company's Chairman, President, and Chief Executive Officer, acted to voluntarily reduce his pension benefit in a letter he submitted to Jane E. Shaw, Ph.D., Chair of the Compensation Committee of the Board of Directors.
Mon Feb 24, 2014
Microvision's Patented Technology Adopted by Leading Fortune Global ...
Microvision's Patented Technology Adopted by Leading Fortune Global 100 Elecronics Company and Rite Aid Signs Agreement with McKesson Corp. Wondering what your next move should be in the market? BullTrends.com can help lead the way.
Fri Feb 21, 2014
Fitch: Drug Channel Aligns Further on McKesson-Rite Aid Deal
Rite Aid Corp.'s decision this week to expand its distribution agreement with McKesson Corp. to include generic pharmaceuticals in addition to branded drugs is in line with prevailing trends in the global drug channel and in healthcare more broadly, according to Fitch Ratings.
Thu Feb 20, 2014
York Hospital Signs Multi-Year IT Outsourcing Contract with McKesson Managed Services
McKesson provides resources and leadership to help manage the rapid growth and complexity of its hospital IT systems, while addressing regulatory requirements and providing overall application support.
Stocks to Watch Thursday: NVIDIA Corporation, Rite Aid Corporation, and Expedia Inc
Today, the stock flew to a six-year high of $6.55, before finishing the session with a 2.2% gain at $6.41.